About Contact Us Careers
Sign In

Dyspepsia Drugs Market - Top Companies and Manufacturers

  • Report ID: 5649
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Companies Dominating the Dyspepsia Drugs Landscape

    • AstraZeneca plc
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Johnson & Johnson Services, Inc.
    • AbbVie Inc.
    • Abbott Laboratories
    • Salix Pharmaceuticals
    • Bayer AG
    • Allergan plc
    • Sanofi
Browse Key Market Insights with Data Illustration:

In the News

  • AstraZeneca plc’s LYNPARZA® (olaparib) and IMFINZI® (durvalumab) significantly improved clinical outcomes and more than quadrupled the median duration of response in patients with advanced or recurrent endometrial cancer that was mismatched for repair.
  • Bayer announced that The Lancet Respiratory Medicine has published the results of the phase IV REPLACE (Riociguat replaces PDE-5i therapy eVeLuated Against PDE-5i Therapy) trial in adults with intermediate-risk pulmonary arterial hypertension (PAH) (WHO group 1). ) ) switched to Adempas® (riociguat) after inadequate response to phosphodiesterase-5 inhibitor (PDE5i) therapy.

Author Credits:  Radhika Pawar


  • Report ID: 5649
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of dyspepsia drugs is estimated at USD 10.49 billion.

The dyspepsia drugs market size was valued at USD 10.12 billion in 2024 and is likely to cross USD 18.16 billion by 2037, expanding at more than 4.6% CAGR during the forecast period i.e., between 2025-2037. The market growth is propelled by rising prevalence of gastroesophageal reflux disease.

Asia Pacific industry is predicted to hold largest revenue share of 35% by 2037, due to high prevalence of H.pylori in the region.

The major players in the market are AstraZeneca plc, Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson Controls, AbbVie Inc., Abbott Laboratories, Salix Pharmaceuticals, Bayer AG, Allergan plc, Sanofi, and others.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample